Addiction Medicine

Questions discussed in this category

When do you consider using phenobarbital over symptom-driven alcohol withdrawal protocols for patients at low-to-moderate risk of withdrawal complications?

1 Answer available

What adjunctive therapies to you recommend for symptom control in acute opioid withdrawal beyond full/partial opioid agonists?

1 Answer available

Do you routinely prescribe naloxone at discharge for patients with a known history of opioid use disorder?

2 Answers available

How do you counsel patients on the risks vs benefits of naltrexone for alcohol use disorder with persistently elevated liver enzymes?

Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...

1 Answer available

Do you have any concerns about administering a Vivitrol injection when a patient has severe coagulopathy and/or thrombocytopenia related to cirrhosis?

1 Answer available

What is your medication of choice when considering outpatient alcohol withdrawal management (diazepam vs chlordiazepoxide vs lorazepam)?

For your recommended medication, are you doing a scheduled set dose, or is it primarily symptom-driven?

2 Answers available

What are your preferred non-benzodiazepine therapies for the hyperactive/agitated phase of methamphetamine withdrawal, both in the hospital and in the office?

Assume QTc is not prolonged, electrolytes are reasonably normal, and the patient is not already on heavy psychotropic polypharmacy.

2 Answers available

How do you approach weaning patients off of buprenorphine?

8 Answers available

Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?

2 Answers available

How do you decide whether to start MAT for opioid use disorder during hospitalization?

1 Answer available

Papers discussed in this category

Journal of addiction medicine, 2021 May-Jun 01

Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series.

The American journal on addictions, 2023 Mar 20

Case series: Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended-release buprenorphine.

Drug and alcohol dependence, 2024 Sep 07

Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.

JAMA psychiatry, 2025 Apr 01

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.

Journal of addiction medicine, 2020 May/Jun

The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management.

Alcohol (Fayetteville, N.Y.), 2014-06

The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS): systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome.

American journal of preventive medicine, 2015-10

Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines.

JHEP reports : innovation in hepatology, 2024 Apr 10

Safety of naltrexone in patients with cirrhosis.

Related Topics